Table 2 Absolute and relative risks for new-onset comorbidities
| Â | % (95% CI) | Â | |||||
|---|---|---|---|---|---|---|---|
| Â | Absolute risks surgery group | Absolute risks control group | Absolute risk reduction | Unadjusted relative Risk | Adjusteda relative Risk | Number need to treat | |
New-DM n (%) | 2.9 (0.9–4.9) | 15.0 (11.6–18.3) | 12.0 (8.1–15.9) | 0.17 (0.08–0.36) | 0.06 (0.02–0.17) | 8 (12–6) | |
New-HTN n (%) | 1.7 (0.5–3.5) | 20.4 (16.1–24.6) | 18.6 (14.2–23.2) | 0.07 (0.02–0.20) | 0.07 (0.02–0.23) | 5 (7–4) | |
New-Dyslipidemia n (%) | 14.3 (9.8–18.8) | 31.5 (26.2–36.8) | 17.1 (10.2–24.1) | 0.36 (0.23–0.57) | 0.45 (0.26–0.78) | 5 (9–4) | |